title: Effect of age on exercise capacity and cardiac reserve in patients with pulmonary atresia with intact ventricular septum after biventricular repair.
abstract: OBJECTIVE
  In patients with pulmonary atresia with intact ventricular septum (PAIVS), biventricular repair is considered to be the optimal treatment option in the absence of significant right ventricular (RV) hypoplasia. However, long-term clinical outcome studies are limited. We evaluated exercise capacity and cardiac function during pharmacological stress in children and young adults with PAIVS after biventricular repair.
  
  
  METHODS
  Ten PAIVS patients after biventricular repair, with a median age of 12 years (range 9-42 years), underwent a cardiopulmonary exercise test, dobutamine stress magnetic resonance imaging (DS-MRI) and delayed contrast enhancement (DCE) MRI.
  
  
  RESULTS
  The patients' ages negatively correlated with exercise capacity (r=-0.72, P=0.01) as well as left (LV) and RV stroke volume (SV) response to pharmacological stress (r=-0.72, P=0.02; and r=-0.64, P=0.04; respectively), Furthermore, older age was associated with decreased RV E/A volume ratio and increased pulmonary late diastolic forward flow percentage (r=0-0.65, P=0.04, r=0.66, P=0.03, respectively). RV E/A volume ratio positively correlated with RV-SV response to DS-MRI (r=0.77, P=0.009). and O2-pulse during physical stress correlated with biventricular SV response to DS-MRI. No RV or LV ventricular myocardial fibrosis was detected.
  
  
  CONCLUSIONS
  In PAIVS patients after biventricular repair exercise capacity and cardiac reserve decrease with age. These findings appear to be related to impaired diastolic RV function and decreased RV filling, indicating that the function of the relatively small RV deteriorates with time.
authors.affiliation: Department of Cardiology, Academic Medical Center, Amsterdam, Netherlands.
authors.forename: Soha
authors.initials: S
authors.lastname: Romeih
authors.forename: Maarten
authors.initials: M
authors.lastname: Groenink
authors.forename: Mart N
authors.initials: MN
authors.lastname: van der Plas
authors.forename: Anje M
authors.initials: AM
authors.lastname: Spijkerboer
authors.forename: Mark G
authors.initials: MG
authors.lastname: Hazekamp
authors.forename: Saskia
authors.initials: S
authors.lastname: Luijnenburg
authors.forename: Barbara J M
authors.initials: BJ
authors.lastname: Mulder
authors.forename: Nico A
authors.initials: NA
authors.lastname: Blom
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002316:Cardiotonic Agents; D002648:Child; D004280:Dobutamine; D005080:Exercise Test; D005260:Female; D005355:Fibrosis / Q000175:diagnosis; D006330:Heart Defects, Congenital / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009206:Myocardium / Q000473:pathology; D018633:Pulmonary Atresia / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D013318:Stroke Volume; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine